Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,317 papers from all fields of science
Search
Sign In
Create Free Account
Amlodipine 10 MG Oral Tablet
Known as:
Amlodipine besylate 10 MILLIGRAM In 1 TABLET ORAL TABLET
, AMLODIPINE BESYLATE 10 mg ORAL TABLET [Amlodipine]
, AMLODIPINE BESYLATE 10MG TAB
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
27 relations
Amlodipine
Amlodipine 10 MG
Amlodipine Besylate
Angina Pectoris, Variant
Expand
Broader (1)
Calcium Channel Blockers
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Amlodipine suppresses Ang-II-induced endothelium dysfunction by diminishing ROCK1 expression
Rulin Xu
,
A. Cai
,
+5 authors
W. Mai
Clinical and experimental hypertension
2016
Corpus ID: 19922964
Abstract Objective: To investigate the effects and mechanisms of amlodipine therapy on endothelium dysfunction induced by…
Expand
2014
2014
Development and Validation of UV Spectrophotometric Method of Amlodipine Besylste in Bulk and Pharmaceutical Formulation
G. R. Babu
,
J. Kumar
,
P. Surekha
,
T. Praveen
,
P. Rao
2014
Corpus ID: 123527247
A simple, accurate, cost effective and reproducible spectrophotometric method has been developed for the estimation of Amlodipine…
Expand
Review
2011
Review
2011
Development of UV spectroscopic method for the estimation of s(-) Amlodipine andHydrochlorothiazide in dosage forms by simultaneous equation method
J. Bagyalakshmi
,
S. M. Philip
,
T. Ravi
2011
Corpus ID: 56183099
S(-) amlodipine is a potent calcium channel blocker used for the treatment of hypertension, congestive heart failure and angina…
Expand
2008
2008
Phthaloyl amlodipine acetone solvate.
Ramón Berenguer Maimó
,
Jorge Medrano Ruperez
,
J. Cabanillas
2008
Corpus ID: 103251149
Acetone solvate of 4- (2-chlorophenyl) -1,4-dihydro-6-methyl-2 - [(2-phthalimidoethoxy) methyl] -3,5-pyridinedicarboxylate 3- and…
Expand
2007
2007
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean…
Sang-Hyun Kim
,
Young‐Dae Kim
,
+12 authors
Hyo‐Soo Kim
Clinical Therapeutics
2007
Corpus ID: 24879151
2006
2006
Comparison of efficacy and tolerability of amlodipine orotate versus amlodipine besylate in adult patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo…
S. Hong
,
T. Ahn
,
+6 authors
D. Lim
Clinical Therapeutics
2006
Corpus ID: 3835966
2006
2006
Efficacy and Safety of Amlodipine Camsylate ( AmodipinTM ) for Treatment of Essential Hypertension
E. Shin
,
W. Chung
,
+4 authors
Y. On
2006
Corpus ID: 91178346
Background and Objectives:Amlodipine camsylate (Amodipin), a newly developed amlodipine formulation, has similar physical…
Expand
2005
2005
Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind…
Hae-Young Lee
,
Hyun-Jae Kang
,
+19 authors
S. Y. Park
Clinical Therapeutics
2005
Corpus ID: 24763110
2005
2005
Efficacy and Safety of Amlodipine Camsylate(Amodipin(TM)) for Treatment of Essential Hypertension
E. Shin
,
W. Chung
,
+4 authors
Y. On
2005
Corpus ID: 71269973
Background and Objectives:Amlodipine camsylate (Amodipin), a newly developed amlodipine formulation, has similar physical…
Expand
2002
2002
Novel amlodipine camphorsulfonate and manufacturing method thereof
ウー、ジョン・ソー
,
キム、ナム・ドゥ
,
ムーン、ユン・ホ
,
リー、キュン・イク
,
リー、グァン・スン
2002
Corpus ID: 102748382
【課題】毒性が低く、且つ、薬剤学的に許容可能な塩の物理化学的な条件を満たすアムロジピンの新規結晶型の酸付加塩を提供する。 【解決手段】アムロジピンを(1S)−(+)−10−カンファースルホン酸(champorsulphonic acid)、(1R)−(−)−10−とカンファースルホン酸、又は(±)−10−カンファースルホン酸と反応させて、溶解度、安定性、非吸湿性、及び錠剤付着性の優れた化学式1の新規なアムロジピンカンファースルホン酸塩を製造する。 【化1】
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE